Bern Pollock uses close to 10 products from different manufacturers to manage his urostomy after bladder cancer. He explains why Medicare bidding concerns him.
|Articles|June 1, 2022
How Patients Can Navigate the BCG Shortage with Dr. Robert Svatek
Advertisement
In this episode of
- What BCG is and how it is used
- What the different strains are
- Why there is a BCG shortage
- What to do if your urologist doesn’t have BCG
- Alternatives to BCG
- The trial Dr. Svatek is doing about the Japanese strain
- The future of BCG treatments
Disclaimer: The views and opinions expressed in this podcast are those of the speakers and guests and do not necessarily reflect the views or positions of the Bladder Cancer Advocacy Network.
Advertisement
Related to this article
A metastatic breast cancer survivor shares how exercise gave her a sense of control while emphasizing why it should never be used to blame people with cancer.
A long-term metastatic ovarian cancer survivor explains how a trifecta of hope, purpose and grace has shaped her life through years of treatment.
Six-year PERSEUS results show 81% of newly diagnosed, transplant-eligible myeloma patients had no cancer progression, with many stopping Darzalex.
A phase 3 trial found that adding Imdelltra to Imfinzi maintenance improved survival in extensive-stage small cell lung cancer, while another drug's application was pulled. Here's what patients should know.
Living with metastatic breast cancer can make Pinktober feel complicated. One patient reflects on awareness, research, loss and remembering the people behind the pink.
A leukemia survivor recalls how bonding with other patients helped his hospital stays go by faster and became a key part of his emotional healing.
Learn how nipple-sparing mastectomy, including endoscopic approaches, may help preserve appearance, reduce scarring and support breast cancer recovery.
Advertisement
Advertisement
Trending on CURE
1
5 Years of Breast Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
Phase 3 Trial Shows Adding Imdelltra to First-Line Treatment Helps Patients With SCLC Live Longer
3
Six Years Later, Most Myeloma Patients on a Darzalex Regimen Are Still Progression-Free
4
10 Cancer Treatment Approvals From September 2026 and What They Mean for You
5